Cameron Turtle

Chief Executive Officer

Cameron Turtle (Chief Executive Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Spyre Therapeutics, Inc. (SYRE). The largest single filing was $1.4M of SYRE (14,184 sh across 3 lots, as filed), executed Aug 3.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 11 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$9.6M

shares × price, as filed

Last traded

Sep 1

Filed Sep 3

Median ADV $134.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $9.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 11 filings

Sector per market data · by filing · past 12 months

Most traded names

SYRE

Spyre Therapeutics, Inc. SYRE · 0 buys · 11 sells 11 filings

Recent filings

SYRESALE Spyre Therapeutics, Inc. View filing → $1.3M
14,600 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 9:33 PM ET SYRESALE Spyre Therapeutics, Inc. View filing → $1.4M
14,184 sh across 3 lots
Exec Aug 3
Filed Aug 5 · 9:31 PM ET SYRESALE Spyre Therapeutics, Inc. View filing → $1.3M
14,410 sh across 2 lots
Exec Jul 1
Filed Jul 2 · 9:32 PM ET SYRESALE Spyre Therapeutics, Inc. View filing → $1.1M
15,000 sh across 3 lots
Exec Jun 1
Filed Jun 3 · 5:30 PM ET SYRESALE Spyre Therapeutics, Inc. View filing → $976K
13,700 sh across 4 lots
Exec May 1
Filed May 1 · 5:30 PM ET SYRESALE Spyre Therapeutics, Inc. View filing → $740K
15,000 sh across 2 lots
Exec Apr 1
Filed Apr 3 · 5:30 PM ET SYRESALE Spyre Therapeutics, Inc. View filing → $633K
15,000 sh across 2 lots
Exec Mar 2
Filed Mar 3 · 5:30 PM ET SYRESALE Spyre Therapeutics, Inc. View filing → $462K
14,043 sh × $32.87
Exec Feb 2
Filed Feb 4 · 5:30 PM ET More filings →